Approximately 600 times a day, the esophagus ferries whatever is in your mouth down to your stomach. It's usually a one-way ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...

Forward-looking statements in this news release include statements regarding the details of the Company's presentation at the upcoming 20th ISDE World Congress for Esophageal Diseases; the Company ...

today announced that the Company will be presenting a poster at the upcoming 20th International Symposium on Digestive Endoscopy ("ISDE") World Congress for Esophageal Diseases to be held in ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

Forward-looking statements in this news release include statements regarding the details of the Company's presentation at the upcoming 20th ISDE World Congress for Esophageal Diseases; the Company's ...

The gastrointestinal microbiome remains an explosively increasing topic of study, assessing the potentially pivotal roles of the microbiome in maintaining health or causality in disease pathogenesis.

In the present study, also signs were improved including lower esophageal sphincter (LES) pressure (from 10 ± 1.58 and, 10.3 ± 1.68 mmHg in the pretreated patients to 16.5 ± 0.6, and 14.1 ± 0. ...